Skip to content
Most recent
Faricimab one step closer
Faricimab has taken one step closer towards clinics in Australia.
Macular disease research highlights
The latest research relevant to optometrists and other health professionals
Optometrists needed for trial study
Participate in new intervention designed to improve glaucoma and diabetic eye care.
Update: Potential new treatments for nAMD and DMO
The US FDA recently approved two treatments: Susvimo® and Vabysmo®.
Research program: AMD and quality of life
Volunteers with AMD sought to build a new computerised instrument.
Reticular pseudodrusen in AMD: Update for optometrists
Read the latest from CERA researchers Dr Zhichao Wu, Himeesh Kumar and Prof Robyn Guymer.
Macular Disease Research Update: November 2021
MDFA’s summary of the past 12 months’ research into macular disease.
Research study measuring the impact of AMD on quality of life
If you have AMD, you could help this MDFA-funded study.
Potential treatment for atrophic AMD on the horizon
Results have now been presented at medical conferences in the USA.